4-butyrolactone has been researched along with Bacterial Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuse, ET; Horikawa, M; Ishiguro, M; Ishii, Y; Miyairi, S; Saito, H; Standiford, TJ; Takabatake, T; Tateda, K; Ueda, C; Yamaguchi, K | 1 |
1 other study(ies) available for 4-butyrolactone and Bacterial Pneumonia
Article | Year |
---|---|
Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection.
Topics: 4-Butyrolactone; Animals; Antibodies, Bacterial; Apoptosis; Cell Line; Colony Count, Microbial; Homoserine; Immune Sera; Injections, Subcutaneous; Lung; Macrophages; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Serum Albumin, Bovine; Tumor Necrosis Factor-alpha; Vaccination; Vaccines, Conjugate; Vaccines, Synthetic | 2006 |